Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | MVF-HER-2(597-626)/MVF-HER-2(266-296) Vaccine |
| Trade Name | |
| Synonyms | |
| Drug Descriptions |
MVF-HER-2(597-626)/MVF-HER-2(266-296) Vaccine is a combination of two chimeric peptide vaccines comprising a promiscuous measles virus (MVF) T cell epitope fused to Erbb2 (Her2) peptides spanning amino acids 597-626 and 266-296, which potentially inhibits Erbb2 (Her2) signaling and induces antibody-dependent cellular cytotoxicity against Erbb2 (Her2)-expressing tumors (PMID: 30804020). |
| DrugClasses | HER2 (ERBB2) Vaccine 15 |
| CAS Registry Number | NA |
| NCIT ID | C97344 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| MVF-HER-2(597-626)/MVF-HER-2(266-296) Vaccine | MVF-HER-2(597-626)/MVF-HER-2(266-296) Vaccine | 0 | 2 |